Liraglutide and weight loss among patients with advanced heart failure and a reduced ejection fraction: insights from the FIGHT trial.

ESC Heart Fail · 2018 · PMC6300815 · PMID 30120812

Europe PMC DOI

hedged sentence

0.0550

closest p · 1.1× alpha

0.0550

boldest claim

The sentences

a numerical trendP = 0.055so close (0.05 < p ≤ 0.1)

After adjustment for baseline NT‐proBNP, change in NT‐proBNP from baseline to last completed visit, baseline congestion score, and change in baseline congestion score to last study visit, there was a numerical trend towards a weight loss treatment difference with liraglutide (−3.94 lbs; 95% CI −7.96, 0.08; P = 0.055).

also in 1,012 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.